Improving the quality of life for people with ALS: the challenge ahead

H Mitsumoto, MD Bene - … Lateral Sclerosis and Other Motor Neuron …, 2000 - Taylor & Francis
In tandem with recent progress in basic and clinical research in amyotrophic lateral sclerosis
(ALS), clinical care and management has improved substantially. Key processes and …

Clinical application of neurotrophic factors: the potential for primary auditory neuron protection

LN Gillespie, RK Shepherd - European Journal of …, 2005 - Wiley Online Library
Sensorineural hearing loss, as a result of damage to or destruction of the sensory epithelia
within the cochlea, is a common cause of deafness. The subsequent degeneration of the …

Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis

M Suzuki, CN Svendsen - Trends in neurosciences, 2008 - cell.com
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease where motor neurons
within the brain and spinal cord are lost, leading to paralysis and death. Certain growth …

Pharmacomimetics of exercise: novel approaches for hippocampally-targeted neuroprotective agents

AM Stranahan, Y Zhou, B Martin… - Current medicinal …, 2009 - ingentaconnect.com
Coordinated and constructive physical activity is correlated with the maintenance of
cognitive function in humans. Voluntary running also enhances neuroplasticity in adult and …

Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics

ND Nelson, M Trail, JN Van, SH Appel… - Journal of palliative …, 2003 - liebertpub.com
Objective: To assess and compare quality of life (QOL) for two groups of patients with
amyotrophic lateral sclerosis (ALS):(1) those reporting a more positive quality of life and (2) …

Motor unit number estimate–based rates of progression of ALS predict patient survival

C Armon, ME Brandstater - Muscle & Nerve: Official Journal of …, 1999 - Wiley Online Library
We have examined, as predictors of survival in patients with amyotrophic lateral sclerosis
(ALS), linear estimates of rates of disease progression (LEP), based on motor unit number …

Brain-derived neurotrophic factor amplifies neurotransmitter responses and promotes synaptic communication in the enteric nervous system

W Boesmans, P Gomes, J Janssens, J Tack… - Gut, 2008 - gut.bmj.com
Background: Besides its role in neuronal growth and differentiation, brain-derived
neurotrophic factor (BDNF) has been implicated in the control of peristalsis where it serves …

Therapeutic potential of neurotrophic factors in neurodegenerative diseases

YS Levy, Y Gilgun-Sherki, E Melamed, D Offen - BioDrugs, 2005 - Springer
There is a vast amount of evidence indicating that neurotrophic factors play a major role in
the development, maintenance, and survival of neurons and neuron-supporting cells such …

Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment

N Lechtzin, J Rothstein, L Clawson… - … Lateral Sclerosis and …, 2002 - Taylor & Francis
Patients with amyotrophic lateral sclerosis (ALS) invariably develop respiratory muscle
weakness and most die from pulmonary complications. There are numerous tests available …

Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ischemia …

KA Galvin, DE Oorschot - Neuroscience, 2003 - Elsevier
This study aimed to investigate whether continuous, low-dose, intracerebral infusion of
either brain-derived neurotrophic factor (BDNF) or neurotrophin-3 (NT-3) could protect …